TF-505, formerly known as FK-687; FR-146687, is a steroid 5α-reductase inhibitor potentially for the treatment of benign prostatic hyperplasia. References: Yao Z, Krzyzanski W, Jusko WJ. Assessment of basic indirect pharmacodynamic response models with physiological limits. J Pharmacokinet Pharmacodyn. 2006 Apr;33(2):167-93. PubMed PMID: 16547797.

纯度：≥98%

CAS：146939-64-2